SELLAS Life Sciences stockholders re-elect two Class II directors and ratify auditor at 2024 annual meeting

SELLAS Life Sciences Group, Inc.

Scheinberg and Kalin re-elected as Class II directors (8.6M/8.8M for; 18.7M broker non-votes).
Ratified Moss Adams LLP as FY2024 auditor: 27.8M for, 1.7M against, 0.5M abstain.
Advisory 'say-on-pay' passed: 6.0M for, 4.8M against, 0.6M abstain; 18.7M broker non-votes.
Quorum: 30.0M shares (51.95%) represented at meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.